Low-Grade Serous Ovarian Cancer
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | KRAS p.G12C | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib | |
| FDA (1) | KRAS p.G12V | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib |